Document is current
Any future updates will be listed below
-
Authors
Riaz, Nazia
Bagge, Roger Olofsson
-
Funding
Funding for this research was provided by:
Swedish Research Council (2020-02446)
Cancerfonden (22 2355 Pj)
Sahlgrenska Universitetssjukhuset (ALFGBG-965024)
Sahlgrenska Universitetssjukhuset (NHV-977897)
Göteborgs Läkaresällskap
Knut och Alice Wallenbergs Stiftelse
Svenska Sällskapet för Medicinsk Forskning
University of Gothenburg
- License Information
-
More Information
Article History
Received: 20 January 2026
Accepted: 25 January 2026
First Online: 9 February 2026
Disclosure
: R.O.B. has received institutional research grants from Bristol-Myers Squibb (BMS), Delcath Systems Inc., Endomagnetics Ltd (Endomag), SkyLineDx, and NeraCare GmbH; speaker honorarium from Bristol-Myers Squibb (BMS), Merck Sharp & Dohme (MSD), Roche, Pfizer, and Pierre-Fabre; has served on advisory boards for Amgen, BD/BARD, Bristol-Myers Squibb (BMS), Delcath, Immunocore, Merck Sharp & Dohme (MSD), Novartis, Roche, and Sanofi Genzyme; and is a shareholder in SATMEG Ventures AB.
